fanta.bio Sample: CNhs11836
18912 enriched TFs, sorted by log₁₀ q-value (most significant first).
| TF | Cell Type | Active overlap | Inactive overlap | log₁₀ p-value | log₁₀ q-value | Fold-enrichment |
|---|---|---|---|---|---|---|
| TP53 SRX1547996 | Dermal fibroblast Epidermis | 1444 / 23238 (6.2%) | 451 / 232380 (0.2%) | −324.0 | −324.0 | 32.02 |
| HIF1A SRX11007095 | HK-2 Kidney | 2874 / 23238 (12.4%) | 1013 / 232380 (0.4%) | −324.0 | −324.0 | 28.37 |
| TP53 SRX19538268 | U2OS Bone | 520 / 23238 (2.2%) | 208 / 232380 (0.1%) | −324.0 | −324.0 | 25.00 |
| TP53 SRX19538274 | U2OS Bone | 517 / 23238 (2.2%) | 207 / 232380 (0.1%) | −324.0 | −324.0 | 24.98 |
| TP53 SRX1547998 | Dermal fibroblast Epidermis | 2064 / 23238 (8.9%) | 857 / 232380 (0.4%) | −324.0 | −324.0 | 24.08 |
| CTNNB1 SRX13991431 | MCF 10A Breast | 554 / 23238 (2.4%) | 234 / 232380 (0.1%) | −324.0 | −324.0 | 23.68 |
| TP53 SRX19538276 | U2OS Bone | 519 / 23238 (2.2%) | 221 / 232380 (0.1%) | −324.0 | −324.0 | 23.48 |
| DVL1 SRX22740968 | MDA-MB-231 Breast | 2124 / 23238 (9.1%) | 916 / 232380 (0.4%) | −324.0 | −324.0 | 23.19 |
| DVL1 SRX22740969 | MDA-MB-231 Breast | 2995 / 23238 (12.9%) | 1354 / 232380 (0.6%) | −324.0 | −324.0 | 22.12 |
| DVL1 SRX22740970 | MDA-MB-231 Breast | 2902 / 23238 (12.5%) | 1335 / 232380 (0.6%) | −324.0 | −324.0 | 21.74 |
| HIF1A SRX20663235 | HK-2 Kidney | 654 / 23238 (2.8%) | 301 / 232380 (0.1%) | −324.0 | −324.0 | 21.73 |
| SCML2 SRX644728 | 293 Kidney | 1785 / 23238 (7.7%) | 849 / 232380 (0.4%) | −324.0 | −324.0 | 21.02 |
| TP53 SRX19538279 | Osteoblasts Bone | 640 / 23238 (2.8%) | 333 / 232380 (0.1%) | −324.0 | −324.0 | 19.22 |
| FOXP1 SRX736067 | LNCAP Prostate | 2314 / 23238 (10.0%) | 1400 / 232380 (0.6%) | −324.0 | −324.0 | 16.53 |
| BRD4 SRX9419935 | BT-474 Breast | 4707 / 23238 (20.3%) | 3276 / 232380 (1.4%) | −324.0 | −324.0 | 14.37 |
| MYH11 SRX265221 | ME-1 Blood | 1074 / 23238 (4.6%) | 761 / 232380 (0.3%) | −324.0 | −324.0 | 14.11 |
| MED1 SRX9419945 | BT-474 Breast | 4669 / 23238 (20.1%) | 3356 / 232380 (1.4%) | −324.0 | −324.0 | 13.91 |
| BRD4 SRX9419937 | BT-474 Breast | 4687 / 23238 (20.2%) | 3374 / 232380 (1.5%) | −324.0 | −324.0 | 13.89 |
| MED1 SRX9419944 | BT-474 Breast | 4553 / 23238 (19.6%) | 3319 / 232380 (1.4%) | −324.0 | −324.0 | 13.72 |
| BRD4 SRX9419938 | BT-474 Breast | 4752 / 23238 (20.4%) | 3501 / 232380 (1.5%) | −324.0 | −324.0 | 13.57 |
| BRD4 SRX9419936 | BT-474 Breast | 4752 / 23238 (20.4%) | 3537 / 232380 (1.5%) | −324.0 | −324.0 | 13.44 |
| MED1 SRX9419946 | BT-474 Breast | 4756 / 23238 (20.5%) | 3545 / 232380 (1.5%) | −324.0 | −324.0 | 13.42 |
| MED1 SRX9419947 | BT-474 Breast | 4575 / 23238 (19.7%) | 3512 / 232380 (1.5%) | −324.0 | −324.0 | 13.03 |
| EZH2 SRX2146136 | LNCAP Prostate | 10383 / 23238 (44.7%) | 10086 / 232380 (4.3%) | −324.0 | −324.0 | 10.29 |
| BRD4 SRX736201 | 90-8TL Neural | 7698 / 23238 (33.1%) | 8391 / 232380 (3.6%) | −324.0 | −324.0 | 9.17 |
| CHD1 SRX2268289 | Mesenchymal stem cells Others | 907 / 23238 (3.9%) | 1157 / 232380 (0.5%) | −324.0 | −324.0 | 7.84 |
| CHD1 SRX2268290 | Mesenchymal stem cells Others | 837 / 23238 (3.6%) | 1189 / 232380 (0.5%) | −324.0 | −324.0 | 7.04 |
| Epitope tags SRX20419389 | Keratinocytes Epidermis | 2388 / 23238 (10.3%) | 3429 / 232380 (1.5%) | −324.0 | −324.0 | 6.96 |
| DNMT3B SRX3275107 | iPS cells Pluripotent stem cell | 852 / 23238 (3.7%) | 1264 / 232380 (0.5%) | −324.0 | −324.0 | 6.74 |
| CHD1 SRX2268291 | Mesenchymal stem cells Others | 1956 / 23238 (8.4%) | 4769 / 232380 (2.1%) | −324.0 | −324.0 | 4.10 |
| HMGB1 SRX2765964 | HUVEC Cardiovascular | 2253 / 23238 (9.7%) | 6724 / 232380 (2.9%) | −324.0 | −324.0 | 3.35 |
| AGO2 SRX4708039 | Hep G2 Liver | 2695 / 23238 (11.6%) | 9928 / 232380 (4.3%) | −324.0 | −324.0 | 2.71 |
| PBX4 SRX2731658 | PC-3 Prostate | 1310 / 23238 (5.6%) | 36845 / 232380 (15.9%) | −324.0 | −324.0 | 0.36 |
| FOXA2 SRX4677296 | CFPAC-1 Pancreas | 870 / 23238 (3.7%) | 26050 / 232380 (11.2%) | −324.0 | −324.0 | 0.33 |
| YAP1 SRX757325 | H2052 Lung | 945 / 23238 (4.1%) | 28484 / 232380 (12.3%) | −324.0 | −324.0 | 0.33 |
| YAP1 SRX757326 | H2052 Lung | 806 / 23238 (3.5%) | 25512 / 232380 (11.0%) | −324.0 | −324.0 | 0.32 |
| FOS SRX150478 | MCF 10A Breast | 872 / 23238 (3.8%) | 28255 / 232380 (12.2%) | −324.0 | −324.0 | 0.31 |
| FOS SRX150477 | MCF 10A Breast | 846 / 23238 (3.6%) | 27550 / 232380 (11.9%) | −324.0 | −324.0 | 0.31 |
| FOS SRX4192880 | MCF 10A Breast | 641 / 23238 (2.8%) | 22298 / 232380 (9.6%) | −324.0 | −324.0 | 0.29 |
| TP53 SRX19538267 | U2OS Bone | 461 / 23238 (2.0%) | 184 / 232380 (0.1%) | −323.3 | −320.4 | 25.05 |
| FOXA1 SRX4815198 | MCF-7 Breast | 1445 / 23238 (6.2%) | 33646 / 232380 (14.5%) | −318.1 | −315.2 | 0.43 |
| TP53 SRX19538275 | U2OS Bone | 469 / 23238 (2.0%) | 210 / 232380 (0.1%) | −317.9 | −315.0 | 22.33 |
| TP53 SRX19538280 | Osteoblasts Bone | 494 / 23238 (2.1%) | 269 / 232380 (0.1%) | −313.9 | −311.0 | 18.36 |
| KAT7 SRX101303 | RKO Digestive tract | 1948 / 23238 (8.4%) | 6768 / 232380 (2.9%) | −313.7 | −310.8 | 2.88 |
| TP53 SRX19538273 | U2OS Bone | 450 / 23238 (1.9%) | 185 / 232380 (0.1%) | −312.9 | −310.1 | 24.32 |
| FOXA1 SRX176862 | MCF-7 Breast | 533 / 23238 (2.3%) | 19386 / 232380 (8.3%) | −310.1 | −307.3 | 0.27 |
| FOS SRX150517 | MCF 10A Breast | 710 / 23238 (3.1%) | 22279 / 232380 (9.6%) | −308.3 | −305.4 | 0.32 |
| FOXA1 SRX176863 | MCF-7 Breast | 489 / 23238 (2.1%) | 18460 / 232380 (7.9%) | −305.1 | −302.2 | 0.26 |
| BRD1 SRX286203 | RKO Digestive tract | 1693 / 23238 (7.3%) | 5434 / 232380 (2.3%) | −304.6 | −301.8 | 3.12 |
| TP53 SRX19538281 | Osteoblasts Bone | 533 / 23238 (2.3%) | 385 / 232380 (0.2%) | −303.5 | −300.7 | 13.84 |
| Epitope tags SRX10549776 | K-562 Blood | 1946 / 23238 (8.4%) | 6928 / 232380 (3.0%) | −301.7 | −298.9 | 2.81 |
| ESR1 SRX7624157 | MCF-7 Breast | 1138 / 23238 (4.9%) | 28610 / 232380 (12.3%) | −301.1 | −298.3 | 0.40 |
| JUNB SRX8488088 | SUM 229PE Breast | 827 / 23238 (3.6%) | 23825 / 232380 (10.3%) | −298.8 | −296.0 | 0.35 |
| IRF3 SRX11453858 | Hep G2 Liver | 366 / 23238 (1.6%) | 80 / 232380 (0.0%) | −295.7 | −292.9 | 45.75 |
| FOXA1 SRX4815197 | MCF-7 Breast | 1083 / 23238 (4.7%) | 27532 / 232380 (11.8%) | −293.6 | −290.8 | 0.39 |
| ESR1 SRX371478 | MCF-7 Breast | 551 / 23238 (2.4%) | 19078 / 232380 (8.2%) | −290.6 | −287.9 | 0.29 |
| FOS SRX150476 | MCF 10A Breast | 755 / 23238 (3.2%) | 22351 / 232380 (9.6%) | −288.7 | −285.9 | 0.34 |
| ESR1 SRX4367193 | MCF-7 Breast | 1469 / 23238 (6.3%) | 32852 / 232380 (14.1%) | −288.1 | −285.4 | 0.45 |
| AR SRX1067071 | LHSAR Prostate | 870 / 23238 (3.7%) | 24013 / 232380 (10.3%) | −284.8 | −282.0 | 0.36 |
| BRPF3 SRX796084 | RKO Digestive tract | 2098 / 23238 (9.0%) | 8175 / 232380 (3.5%) | −281.1 | −278.4 | 2.57 |
| BRPF3 SRX796085 | RKO Digestive tract | 1509 / 23238 (6.5%) | 4721 / 232380 (2.0%) | −280.2 | −277.5 | 3.20 |
| NANOG SRX3288566 | hESC H9 Pluripotent stem cell | 307 / 23238 (1.3%) | 14383 / 232380 (6.2%) | −280.0 | −277.3 | 0.21 |
| NCOA3 SRX8949281 | ZR-75-1 Breast | 509 / 23238 (2.2%) | 17971 / 232380 (7.7%) | −278.3 | −275.5 | 0.28 |
| FOXA1 SRX371483 | MCF-7 Breast | 500 / 23238 (2.2%) | 17761 / 232380 (7.6%) | −276.4 | −273.6 | 0.28 |
| ESR1 SRX371469 | MCF-7 Breast | 459 / 23238 (2.0%) | 17022 / 232380 (7.3%) | −275.5 | −272.8 | 0.27 |
| BRPF3 SRX796086 | RKO Digestive tract | 2016 / 23238 (8.7%) | 7766 / 232380 (3.3%) | −275.1 | −272.4 | 2.60 |
| RUNX1 SRX2513054 | 293 Kidney | 4325 / 23238 (18.6%) | 24113 / 232380 (10.4%) | −274.5 | −271.8 | 1.79 |
| NCOA3 SRX8949280 | ZR-75-1 Breast | 520 / 23238 (2.2%) | 18039 / 232380 (7.8%) | −274.4 | −271.7 | 0.29 |
| ESR1 SRX20282961 | MCF-7 Breast | 567 / 23238 (2.4%) | 18822 / 232380 (8.1%) | −274.1 | −271.4 | 0.30 |
| FOXA1 SRX1161177 | MCF-7 Breast | 446 / 23238 (1.9%) | 16749 / 232380 (7.2%) | −274.0 | −271.3 | 0.27 |
| FOXA1 SRX371481 | MCF-7 Breast | 467 / 23238 (2.0%) | 17104 / 232380 (7.4%) | −273.7 | −271.0 | 0.27 |
| ESR1 SRX7624156 | MCF-7 Breast | 732 / 23238 (3.2%) | 21454 / 232380 (9.2%) | −272.8 | −270.2 | 0.34 |
| FOXA2 SRX5504125 | CFPAC-1 Pancreas | 560 / 23238 (2.4%) | 18611 / 232380 (8.0%) | −271.2 | −268.6 | 0.30 |
| TP53 SRX19538269 | U2OS Bone | 560 / 23238 (2.4%) | 567 / 232380 (0.2%) | −271.1 | −268.5 | 9.88 |
| TP53 SRX396254 | Fibroblasts Others | 1262 / 23238 (5.4%) | 3515 / 232380 (1.5%) | −270.9 | −268.2 | 3.59 |
| FOXA1 SRX3931044 | MCF-7 Breast | 1006 / 23238 (4.3%) | 25497 / 232380 (11.0%) | −268.8 | −266.2 | 0.39 |
| AR SRX1067070 | LHSAR Prostate | 1138 / 23238 (4.9%) | 27426 / 232380 (11.8%) | −268.8 | −266.1 | 0.41 |
| EED SRX8175103 | ES cells Pluripotent stem cell | 2794 / 23238 (12.0%) | 13048 / 232380 (5.6%) | −266.9 | −264.3 | 2.14 |
| FOXA1 SRX371482 | MCF-7 Breast | 668 / 23238 (2.9%) | 20236 / 232380 (8.7%) | −266.9 | −264.3 | 0.33 |
| GATA3 SRX190239 | MCF-7 Breast | 677 / 23238 (2.9%) | 20370 / 232380 (8.8%) | −266.7 | −264.1 | 0.33 |
| ESR1 SRX176860 | MCF-7 Breast | 764 / 23238 (3.3%) | 21739 / 232380 (9.4%) | −266.5 | −263.9 | 0.35 |
| JUN SRX17561461 | LPS141 Adipocyte | 653 / 23238 (2.8%) | 19975 / 232380 (8.6%) | −266.3 | −263.7 | 0.33 |
| AGO2 SRX6783958 | Hep G2 Liver | 1675 / 23238 (7.2%) | 5851 / 232380 (2.5%) | −265.9 | −263.3 | 2.86 |
| TLE3 SRX4815191 | MCF-7 Breast | 431 / 23238 (1.9%) | 16163 / 232380 (7.0%) | −263.7 | −261.1 | 0.27 |
| AGO2 SRX6783957 | Hep G2 Liver | 1693 / 23238 (7.3%) | 6005 / 232380 (2.6%) | −262.7 | −260.1 | 2.82 |
| AR SRX10820653 | LNCAP Prostate | 417 / 23238 (1.8%) | 235 / 232380 (0.1%) | −261.7 | −259.1 | 17.74 |
| ESR1 SRX371471 | ZR-75-1 Breast | 495 / 23238 (2.1%) | 17201 / 232380 (7.4%) | −261.4 | −258.8 | 0.29 |
| FOSL1 SRX14181206 | MSK-PCa3 Prostate | 800 / 23238 (3.4%) | 22083 / 232380 (9.5%) | −260.3 | −257.7 | 0.36 |
| ESR1 SRX176861 | MCF-7 Breast | 780 / 23238 (3.4%) | 21749 / 232380 (9.4%) | −259.6 | −257.0 | 0.36 |
| FOS SRX4192879 | MCF 10A Breast | 522 / 23238 (2.2%) | 17563 / 232380 (7.6%) | −258.6 | −256.0 | 0.30 |
| ESR1 SRX371470 | ZR-75-1 Breast | 411 / 23238 (1.8%) | 15648 / 232380 (6.7%) | −258.4 | −255.8 | 0.26 |
| FOXA1 SRX9419950 | SK-BR-3 Breast | 811 / 23238 (3.5%) | 22165 / 232380 (9.5%) | −257.8 | −255.2 | 0.37 |
| HMGB1 SRX10567335 | HUVEC Cardiovascular | 1889 / 23238 (8.1%) | 7279 / 232380 (3.1%) | −257.0 | −254.4 | 2.60 |
| ESR1 SRX371479 | MCF-7 Breast | 426 / 23238 (1.8%) | 15840 / 232380 (6.8%) | −256.2 | −253.6 | 0.27 |
| FOXA2 SRX6441753 | CFPAC-1 Pancreas | 607 / 23238 (2.6%) | 18885 / 232380 (8.1%) | −256.1 | −253.5 | 0.32 |
| ESR1 SRX20282960 | MCF-7 Breast | 535 / 23238 (2.3%) | 17674 / 232380 (7.6%) | −255.2 | −252.7 | 0.30 |
| FOXA1 SRX1161176 | MCF-7 Breast | 446 / 23238 (1.9%) | 16126 / 232380 (6.9%) | −254.1 | −251.6 | 0.28 |
| TP53 SRX19538270 | U2OS Bone | 534 / 23238 (2.3%) | 558 / 232380 (0.2%) | −254.1 | −251.6 | 9.57 |
| KAT6A SRX20971022 | Fibroblasts Others | 321 / 23238 (1.4%) | 78 / 232380 (0.0%) | −254.0 | −251.5 | 41.15 |
| Epitope tags DRX443510 | 293 Kidney | 2024 / 23238 (8.7%) | 8177 / 232380 (3.5%) | −253.8 | −251.3 | 2.48 |
| JUN SRX11051031 | hTERT RPE-1 Neural | 1621 / 23238 (7.0%) | 33508 / 232380 (14.4%) | −252.3 | −249.8 | 0.48 |
| IRF3 SRX11453861 | Hep G2 Liver | 319 / 23238 (1.4%) | 78 / 232380 (0.0%) | −252.1 | −249.6 | 40.90 |
| JUNB SRX8488073 | SUM 229PE Breast | 890 / 23238 (3.8%) | 23145 / 232380 (10.0%) | −251.6 | −249.1 | 0.38 |
| FOXA1 SRX9419949 | SK-BR-3 Breast | 686 / 23238 (3.0%) | 19998 / 232380 (8.6%) | −251.5 | −249.0 | 0.34 |
| NCOA3 SRX8949279 | ZR-75-1 Breast | 697 / 23238 (3.0%) | 20169 / 232380 (8.7%) | −251.5 | −249.0 | 0.35 |
| FOXA1 SRX1161175 | MCF-7 Breast | 337 / 23238 (1.5%) | 14067 / 232380 (6.1%) | −250.4 | −247.9 | 0.24 |
| RELA SRX2207673 | HUVEC Cardiovascular | 1743 / 23238 (7.5%) | 35056 / 232380 (15.1%) | −250.4 | −247.9 | 0.50 |
| SMARCC1 SRX11379507 | Liposarcoma, Myxoid Adipocyte | 1015 / 23238 (4.4%) | 24939 / 232380 (10.7%) | −250.1 | −247.6 | 0.41 |
| MEAF6 DRX234811 | 293 Kidney | 2298 / 23238 (9.9%) | 10033 / 232380 (4.3%) | −250.0 | −247.5 | 2.29 |
| ESR1 SRX371476 | MCF-7 Breast | 340 / 23238 (1.5%) | 14103 / 232380 (6.1%) | −249.7 | −247.3 | 0.24 |
| ING5 SRX286202 | RKO Digestive tract | 1805 / 23238 (7.8%) | 6893 / 232380 (3.0%) | −248.7 | −246.3 | 2.62 |
| FOXA1 SRX1161173 | MCF-7 Breast | 370 / 23238 (1.6%) | 14603 / 232380 (6.3%) | −248.3 | −245.8 | 0.25 |
| ESR1 SRX1531791 | MCF-7 Breast | 459 / 23238 (2.0%) | 16118 / 232380 (6.9%) | −246.9 | −244.4 | 0.28 |
| MEAF6 DRX300417 | 293 Kidney | 2113 / 23238 (9.1%) | 8882 / 232380 (3.8%) | −246.5 | −244.1 | 2.38 |
| JUN SRX4192884 | MCF 10A Breast | 371 / 23238 (1.6%) | 14556 / 232380 (6.3%) | −246.3 | −243.8 | 0.25 |
| ESR1 SRX20282939 | MCF-7 Breast | 552 / 23238 (2.4%) | 17657 / 232380 (7.6%) | −246.1 | −243.7 | 0.31 |
| JUNB SRX10119396 | MDA-MB-231 Breast | 470 / 23238 (2.0%) | 16283 / 232380 (7.0%) | −246.1 | −243.6 | 0.29 |
| ESR1 SRX371467 | MCF-7 Breast | 503 / 23238 (2.2%) | 16819 / 232380 (7.2%) | −245.4 | −242.9 | 0.30 |
| DNMT3B SRX3275108 | iPS cells Pluripotent stem cell | 622 / 23238 (2.7%) | 886 / 232380 (0.4%) | −244.6 | −242.2 | 7.02 |
| RELA SRX2207672 | HUVEC Cardiovascular | 1887 / 23238 (8.1%) | 36710 / 232380 (15.8%) | −244.6 | −242.1 | 0.51 |
| ESR1 SRX194569 | MCF-7 Breast | 505 / 23238 (2.2%) | 16779 / 232380 (7.2%) | −243.2 | −240.7 | 0.30 |
| SMARCA2 SRX8119674 | MRC-5 Lung | 1168 / 23238 (5.0%) | 26847 / 232380 (11.6%) | −242.2 | −239.8 | 0.44 |
| FOXA1 SRX1161187 | ZR-75-1 Breast | 464 / 23238 (2.0%) | 16014 / 232380 (6.9%) | −240.9 | −238.5 | 0.29 |
| SMARCA4 SRX5212366 | Mel270 Others | 644 / 23238 (2.8%) | 18918 / 232380 (8.1%) | −239.4 | −237.0 | 0.34 |
| JUNB SRX8488089 | SUM 229PE Breast | 467 / 23238 (2.0%) | 16008 / 232380 (6.9%) | −239.1 | −236.7 | 0.29 |
| GATA3 SRX190194 | SK-N-SH Neural | 1169 / 23238 (5.0%) | 26710 / 232380 (11.5%) | −238.4 | −236.0 | 0.44 |
| FOXA1 SRX8537740 | SUM 44PE Breast | 1087 / 23238 (4.7%) | 25500 / 232380 (11.0%) | −237.3 | −234.9 | 0.43 |
| FOSL2 SRX10640865 | SK-MEL-147 Epidermis | 953 / 23238 (4.1%) | 23550 / 232380 (10.1%) | −237.2 | −234.8 | 0.40 |
| FOXA2 SRX6441752 | CFPAC-1 Pancreas | 516 / 23238 (2.2%) | 16742 / 232380 (7.2%) | −236.5 | −234.1 | 0.31 |
| SMARCA4 SRX5075170 | Neural progenitor cells Neural | 1204 / 23238 (5.2%) | 27075 / 232380 (11.7%) | −235.0 | −232.6 | 0.44 |
| AR SRX9469988 | LAPC-4 Prostate | 650 / 23238 (2.8%) | 18864 / 232380 (8.1%) | −235.0 | −232.6 | 0.34 |
| ESR1 SRX194572 | MCF-7 Breast | 301 / 23238 (1.3%) | 12931 / 232380 (5.6%) | −234.9 | −232.5 | 0.23 |
| SMARCA4 SRX5212357 | Mel270 Others | 706 / 23238 (3.0%) | 19735 / 232380 (8.5%) | −234.8 | −232.4 | 0.36 |
| TCF12 SRX190356 | SK-N-SH Neural | 1358 / 23238 (5.8%) | 29204 / 232380 (12.6%) | −234.6 | −232.2 | 0.47 |
| FOXA1 SRX9419951 | SK-BR-3 Breast | 640 / 23238 (2.8%) | 18687 / 232380 (8.0%) | −234.5 | −232.1 | 0.34 |
| JUN SRX11051032 | hTERT RPE-1 Neural | 1657 / 23238 (7.1%) | 33234 / 232380 (14.3%) | −234.3 | −231.9 | 0.50 |
| SMARCA2 SRX8119677 | MeT-5A Others | 808 / 23238 (3.5%) | 21275 / 232380 (9.2%) | −234.2 | −231.8 | 0.38 |
| YAP1 SRX5718140 | 293 Kidney | 850 / 23238 (3.7%) | 21897 / 232380 (9.4%) | −233.9 | −231.5 | 0.39 |
| FOXA1 SRX1161189 | ZR-75-1 Breast | 443 / 23238 (1.9%) | 15403 / 232380 (6.6%) | −233.1 | −230.7 | 0.29 |
| CHD7 SRX3581507 | iPS cells Pluripotent stem cell | 370 / 23238 (1.6%) | 14130 / 232380 (6.1%) | −233.1 | −230.7 | 0.26 |
| FOSL2 SRX10640866 | SK-MEL-147 Epidermis | 968 / 23238 (4.2%) | 23605 / 232380 (10.2%) | −232.8 | −230.4 | 0.41 |
| FOXA1 SRX1161190 | ZR-75-1 Breast | 438 / 23238 (1.9%) | 15304 / 232380 (6.6%) | −232.7 | −230.3 | 0.29 |
| GATA3 SRX176864 | MCF-7 Breast | 356 / 23238 (1.5%) | 13836 / 232380 (6.0%) | −231.6 | −229.3 | 0.26 |
| JUNB SRX10119386 | MCF 10A Breast | 431 / 23238 (1.9%) | 15145 / 232380 (6.5%) | −231.5 | −229.1 | 0.28 |
| ESR1 SRX20282954 | MCF-7 Breast | 548 / 23238 (2.4%) | 17099 / 232380 (7.4%) | −231.4 | −229.0 | 0.32 |
| TP53 SRX19538282 | Osteoblasts Bone | 451 / 23238 (1.9%) | 408 / 232380 (0.2%) | −231.4 | −229.0 | 11.05 |
| CIC SRX13262055 | Astrocytes Neural | 3974 / 23238 (17.1%) | 22711 / 232380 (9.8%) | −231.2 | −228.9 | 1.75 |
| ESR1 SRX371468 | MCF-7 Breast | 311 / 23238 (1.3%) | 12986 / 232380 (5.6%) | −230.6 | −228.3 | 0.24 |
| JUNB SRX10119395 | MDA-MB-231 Breast | 443 / 23238 (1.9%) | 15314 / 232380 (6.6%) | −230.4 | −228.0 | 0.29 |
| FOXA1 SRX6441747 | CFPAC-1 Pancreas | 455 / 23238 (2.0%) | 15517 / 232380 (6.7%) | −230.3 | −227.9 | 0.29 |
| FOXA1 SRX371480 | MCF-7 Breast | 327 / 23238 (1.4%) | 13261 / 232380 (5.7%) | −230.0 | −227.6 | 0.25 |
| FOXA1 SRX100454 | T-47D Breast | 652 / 23238 (2.8%) | 18715 / 232380 (8.1%) | −229.8 | −227.5 | 0.35 |
| 5-mC SRX882970 | LNCAP Prostate | 3719 / 23238 (16.0%) | 20786 / 232380 (8.9%) | −229.6 | −227.3 | 1.79 |
| SMARCA4 SRX5075176 | Neural progenitor cells Neural | 1183 / 23238 (5.1%) | 26560 / 232380 (11.4%) | −229.4 | −227.1 | 0.45 |
| JUN SRX883584 | MDA-MB-231 Breast | 785 / 23238 (3.4%) | 20754 / 232380 (8.9%) | −229.3 | −227.0 | 0.38 |
| SMARCA4 SRX5212362 | Mel270 Others | 861 / 23238 (3.7%) | 21892 / 232380 (9.4%) | −229.3 | −226.9 | 0.39 |
| ARID1A SRX5089376 | MCF-7 Breast | 425 / 23238 (1.8%) | 14962 / 232380 (6.4%) | −229.0 | −226.7 | 0.28 |
| ESR1 SRX20282972 | MCF-7 Breast | 569 / 23238 (2.4%) | 17320 / 232380 (7.5%) | −227.8 | −225.5 | 0.33 |
| JUNB SRX8488074 | SUM 229PE Breast | 659 / 23238 (2.8%) | 18753 / 232380 (8.1%) | −227.8 | −225.5 | 0.35 |
| RAC1 SRX10365543 | MCF-7 Breast | 251 / 23238 (1.1%) | 11728 / 232380 (5.0%) | −226.4 | −224.1 | 0.21 |
| FOXA1 SRX6441749 | CFPAC-1 Pancreas | 451 / 23238 (1.9%) | 15323 / 232380 (6.6%) | −226.4 | −224.0 | 0.29 |
| JUNB SRX4192882 | MCF 10A Breast | 380 / 23238 (1.6%) | 14093 / 232380 (6.1%) | −226.2 | −223.9 | 0.27 |
| DNMT3B SRX2862488 | hESC HUES8 Pluripotent stem cell | 611 / 23238 (2.6%) | 953 / 232380 (0.4%) | −225.2 | −222.9 | 6.41 |
| DNA-RNA hybrid SRX21658478 | U2OS Bone | 820 / 23238 (3.5%) | 1817 / 232380 (0.8%) | −224.4 | −222.1 | 4.51 |
| JUN SRX11051045 | hTERT RPE-1 Neural | 1616 / 23238 (7.0%) | 32221 / 232380 (13.9%) | −223.3 | −221.0 | 0.50 |
| EED SRX8175102 | ES cells Pluripotent stem cell | 2282 / 23238 (9.8%) | 10476 / 232380 (4.5%) | −223.3 | −221.0 | 2.18 |
| FOXA1 SRX15430994 | SK-BR-3 Breast | 502 / 23238 (2.2%) | 16064 / 232380 (6.9%) | −222.9 | −220.6 | 0.31 |
| FOXA1 SRX1161192 | ZR-75-1 Breast | 470 / 23238 (2.0%) | 15527 / 232380 (6.7%) | −222.8 | −220.5 | 0.30 |
| 5-mC SRX882968 | LNCAP Prostate | 3663 / 23238 (15.8%) | 20565 / 232380 (8.8%) | −222.8 | −220.5 | 1.78 |
| ESR1 SRX10365536 | MCF-7 Breast | 256 / 23238 (1.1%) | 11699 / 232380 (5.0%) | −222.1 | −219.8 | 0.22 |
| ESR1 SRX2943591 | MCF-7 Breast | 344 / 23238 (1.5%) | 13288 / 232380 (5.7%) | −220.9 | −218.6 | 0.26 |
| ESR1 SRX10365535 | MCF-7 Breast | 411 / 23238 (1.8%) | 14462 / 232380 (6.2%) | −220.8 | −218.5 | 0.28 |
| GATA3 SRX5057632 | MCF-7 Breast | 329 / 23238 (1.4%) | 13003 / 232380 (5.6%) | −220.5 | −218.2 | 0.25 |
| FOXA2 SRX6441750 | CFPAC-1 Pancreas | 455 / 23238 (2.0%) | 15170 / 232380 (6.5%) | −219.7 | −217.4 | 0.30 |
| BRD4 SRX736204 | 90-8TL Neural | 1203 / 23238 (5.2%) | 3799 / 232380 (1.6%) | −219.3 | −217.0 | 3.17 |
| FOXA1 SRX3923514 | MCF-7 Breast | 520 / 23238 (2.2%) | 16226 / 232380 (7.0%) | −219.0 | −216.7 | 0.32 |
| FOXA1 SRX1787653 | MCF-7 Breast | 413 / 23238 (1.8%) | 14433 / 232380 (6.2%) | −218.9 | −216.6 | 0.29 |
| SMARCA4 SRX5075169 | Neural progenitor cells Neural | 1010 / 23238 (4.3%) | 23678 / 232380 (10.2%) | −218.7 | −216.5 | 0.43 |
| NANOG SRX20532160 | hESC HUES8 Pluripotent stem cell | 1524 / 23238 (6.6%) | 30785 / 232380 (13.2%) | −218.4 | −216.2 | 0.50 |
| FOXA1 SRX8537741 | SUM 44PE Breast | 858 / 23238 (3.7%) | 21444 / 232380 (9.2%) | −218.3 | −216.1 | 0.40 |
| FOXA1 SRX1161174 | MCF-7 Breast | 534 / 23238 (2.3%) | 16429 / 232380 (7.1%) | −218.2 | −216.0 | 0.33 |
| ESR1 SRX4367192 | MCF-7 Breast | 1059 / 23238 (4.6%) | 24334 / 232380 (10.5%) | −217.5 | −215.3 | 0.44 |
| FOXA1 SRX1389381 | CFPAC-1 Pancreas | 448 / 23238 (1.9%) | 14969 / 232380 (6.4%) | −217.0 | −214.8 | 0.30 |
| ESR1 SRX371475 | BT-474 Breast | 241 / 23238 (1.0%) | 11252 / 232380 (4.8%) | −216.7 | −214.5 | 0.21 |
| FOXA1 SRX825395 | CFPAC-1 Pancreas | 485 / 23238 (2.1%) | 15572 / 232380 (6.7%) | −216.7 | −214.4 | 0.31 |
| FOSL2 SRX3367141 | SK-MEL-147 Epidermis | 726 / 23238 (3.1%) | 19394 / 232380 (8.3%) | −216.6 | −214.4 | 0.37 |
| FOXA1 SRX1161188 | ZR-75-1 Breast | 356 / 23238 (1.5%) | 13368 / 232380 (5.8%) | −216.6 | −214.3 | 0.27 |
| RAC1 SRX10365541 | MCF-7 Breast | 266 / 23238 (1.1%) | 11704 / 232380 (5.0%) | −215.8 | −213.6 | 0.23 |
| EP300 SRX027482 | hESC H9 Pluripotent stem cell | 440 / 23238 (1.9%) | 14754 / 232380 (6.3%) | −214.7 | −212.5 | 0.30 |
| SMARCA4 SRX5212371 | Mel270 Others | 731 / 23238 (3.1%) | 19392 / 232380 (8.3%) | −214.5 | −212.2 | 0.38 |
| FOXA1 SRX11222437 | MCF-7 Breast | 364 / 23238 (1.6%) | 13438 / 232380 (5.8%) | −214.4 | −212.2 | 0.27 |
| VGLL1 SRX24602130 | BT-20 Breast | 544 / 23238 (2.3%) | 16432 / 232380 (7.1%) | −213.5 | −211.3 | 0.33 |
| JUN SRX11051046 | hTERT RPE-1 Neural | 1489 / 23238 (6.4%) | 30085 / 232380 (12.9%) | −213.0 | −210.8 | 0.49 |
| FOXA1 SRX1161191 | ZR-75-1 Breast | 408 / 23238 (1.8%) | 14151 / 232380 (6.1%) | −212.9 | −210.7 | 0.29 |
| STAT3 SRX150630 | MCF 10A Breast | 472 / 23238 (2.0%) | 15216 / 232380 (6.5%) | −212.5 | −210.2 | 0.31 |
| ESR1 SRX20282973 | MCF-7 Breast | 637 / 23238 (2.7%) | 17847 / 232380 (7.7%) | −211.8 | −209.6 | 0.36 |
| STAT3 SRX2020842 | HCC70 Breast | 935 / 23238 (4.0%) | 22307 / 232380 (9.6%) | −211.2 | −209.0 | 0.42 |
| AR SRX10820651 | LNCAP Prostate | 423 / 23238 (1.8%) | 405 / 232380 (0.2%) | −210.9 | −208.6 | 10.44 |
| FOXA2 SRX3230382 | Hep G2 Liver | 720 / 23238 (3.1%) | 19092 / 232380 (8.2%) | −210.8 | −208.6 | 0.38 |
| STAT3 SRX150479 | MCF 10A Breast | 480 / 23238 (2.1%) | 15294 / 232380 (6.6%) | −210.8 | −208.5 | 0.31 |
| FOXA1 SRX100506 | Hep G2 Liver | 699 / 23238 (3.0%) | 18769 / 232380 (8.1%) | −210.7 | −208.5 | 0.37 |
| RELA SRX5938177 | FaDu Others | 472 / 23238 (2.0%) | 15139 / 232380 (6.5%) | −210.1 | −207.9 | 0.31 |
| FOSL2 SRX10640867 | SK-MEL-147 Epidermis | 917 / 23238 (3.9%) | 21988 / 232380 (9.5%) | −209.8 | −207.5 | 0.42 |
| WWTR1 SRX10119367 | MCF 10A Breast | 614 / 23238 (2.6%) | 17405 / 232380 (7.5%) | −209.5 | −207.3 | 0.35 |
| TEAD1 SRX3401272 | MCF-7 Breast | 393 / 23238 (1.7%) | 13770 / 232380 (5.9%) | −209.0 | −206.8 | 0.29 |
| Epitope tags SRX8080565 | Mammary gland adenocarcinoma Breast | 239 / 23238 (1.0%) | 10983 / 232380 (4.7%) | −209.0 | −206.8 | 0.22 |
| ESR1 SRX330067 | MCF-7 Breast | 477 / 23238 (2.1%) | 15170 / 232380 (6.5%) | −208.6 | −206.4 | 0.31 |
| FOXA1 SRX11222441 | MCF-7 Breast | 401 / 23238 (1.7%) | 13892 / 232380 (6.0%) | −208.6 | −206.4 | 0.29 |
| ESR1 SRX20282940 | MCF-7 Breast | 579 / 23238 (2.5%) | 16813 / 232380 (7.2%) | −208.4 | −206.2 | 0.34 |
| JADE3 DRX300415 | 293 Kidney | 2003 / 23238 (8.6%) | 8906 / 232380 (3.8%) | −208.3 | −206.1 | 2.25 |
| DNA-RNA hybrid SRX21658481 | U2OS Bone | 806 / 23238 (3.5%) | 1891 / 232380 (0.8%) | −208.2 | −206.0 | 4.26 |
| NANOG SRX20532161 | hESC HUES8 Pluripotent stem cell | 1383 / 23238 (6.0%) | 28429 / 232380 (12.2%) | −207.7 | −205.5 | 0.49 |
| NKX2-1 SRX2164786 | A549 Lung | 879 / 23238 (3.8%) | 21344 / 232380 (9.2%) | −207.4 | −205.2 | 0.41 |
| ESR1 SRX20282955 | MCF-7 Breast | 564 / 23238 (2.4%) | 16534 / 232380 (7.1%) | −207.2 | −205.0 | 0.34 |
| CARM1 SRX10562203 | MDA-MB-231 Breast | 309 / 23238 (1.3%) | 144 / 232380 (0.1%) | −206.9 | −204.7 | 21.46 |
| PBX3 SRX190343 | SK-N-SH Neural | 1109 / 23238 (4.8%) | 24611 / 232380 (10.6%) | −206.7 | −204.5 | 0.45 |
| ESR1 SRX2881002 | MCF-7 Breast | 504 / 23238 (2.2%) | 15540 / 232380 (6.7%) | −206.5 | −204.3 | 0.32 |
| CEBPB SRX150632 | HeLa Uterus | 1202 / 23238 (5.2%) | 25888 / 232380 (11.1%) | −206.3 | −204.1 | 0.46 |
| SS18 SRX10640842 | SK-MEL-147 Epidermis | 686 / 23238 (3.0%) | 18407 / 232380 (7.9%) | −206.3 | −204.1 | 0.37 |
| FOXA1 SRX11222442 | MCF-7 Breast | 346 / 23238 (1.5%) | 12866 / 232380 (5.5%) | −206.3 | −204.1 | 0.27 |
| ESR1 SRX371477 | MCF-7 Breast | 256 / 23238 (1.1%) | 11221 / 232380 (4.8%) | −206.1 | −203.9 | 0.23 |
| BMI1 SRX644729 | 293 Kidney | 311 / 23238 (1.3%) | 151 / 232380 (0.1%) | −205.5 | −203.3 | 20.60 |
| AR SRX9109110 | MDA-MB-453 Breast | 1003 / 23238 (4.3%) | 23047 / 232380 (9.9%) | −205.1 | −203.0 | 0.44 |
| ESR1 SRX371474 | BT-474 Breast | 230 / 23238 (1.0%) | 10695 / 232380 (4.6%) | −205.1 | −202.9 | 0.22 |
| YAP1 SRX10119364 | MCF 10A Breast | 440 / 23238 (1.9%) | 14434 / 232380 (6.2%) | −204.9 | −202.8 | 0.30 |
| ESR1 SRX20282971 | MCF-7 Breast | 529 / 23238 (2.3%) | 15890 / 232380 (6.8%) | −204.8 | −202.6 | 0.33 |
| FOSL2 SRX190296 | SK-N-SH Neural | 711 / 23238 (3.1%) | 18725 / 232380 (8.1%) | −204.5 | −202.4 | 0.38 |
| NR1H3 SRX1538760 | HT-29 Digestive tract | 505 / 23238 (2.2%) | 15469 / 232380 (6.7%) | −203.8 | −201.7 | 0.33 |
| LEO1 SRX1873456 | SEM Blood | 1879 / 23238 (8.1%) | 8179 / 232380 (3.5%) | −203.5 | −201.3 | 2.30 |
| EP300 SRX150579 | HeLa Uterus | 344 / 23238 (1.5%) | 12734 / 232380 (5.5%) | −203.3 | −201.2 | 0.27 |
| FOXA2 SRX6441755 | CFPAC-1 Pancreas | 408 / 23238 (1.8%) | 13837 / 232380 (6.0%) | −203.2 | −201.0 | 0.29 |
| ESR1 SRX1161185 | ZR-75-1 Breast | 248 / 23238 (1.1%) | 10978 / 232380 (4.7%) | −203.1 | −201.0 | 0.23 |
| FOXA1 SRX9419952 | SK-BR-3 Breast | 508 / 23238 (2.2%) | 15487 / 232380 (6.7%) | −203.0 | −200.8 | 0.33 |
| DAXX SRX1021630 | PC-3 Prostate | 536 / 23238 (2.3%) | 15928 / 232380 (6.9%) | −202.7 | −200.5 | 0.34 |
| AR SRX1067067 | LHSAR Prostate | 910 / 23238 (3.9%) | 21604 / 232380 (9.3%) | −202.4 | −200.3 | 0.42 |
| ARID1A SRX5089379 | MCF-7 Breast | 538 / 23238 (2.3%) | 15937 / 232380 (6.9%) | −202.0 | −199.8 | 0.34 |
| NANOG SRX5286327 | ES cells Pluripotent stem cell | 375 / 23238 (1.6%) | 13216 / 232380 (5.7%) | −201.5 | −199.4 | 0.28 |
| STAT3 SRX150536 | MCF 10A Breast | 600 / 23238 (2.6%) | 16899 / 232380 (7.3%) | −201.3 | −199.2 | 0.36 |
| ESR1 SRX10365532 | MCF-7 Breast | 288 / 23238 (1.2%) | 11661 / 232380 (5.0%) | −201.1 | −199.0 | 0.25 |
| PRRX1 SRX15235713 | Hs 578T Breast | 658 / 23238 (2.8%) | 17788 / 232380 (7.7%) | −201.0 | −198.9 | 0.37 |
| ESR2 SRX8272750 | HT-29 Digestive tract | 651 / 23238 (2.8%) | 1265 / 232380 (0.5%) | −201.0 | −198.9 | 5.15 |
| FOXA1 SRX3931043 | MCF-7 Breast | 552 / 23238 (2.4%) | 16127 / 232380 (6.9%) | −200.9 | −198.8 | 0.34 |
| DNA-RNA hybrid SRX20083260 | SH-SY5Y Neural | 1151 / 23238 (5.0%) | 3748 / 232380 (1.6%) | −200.8 | −198.7 | 3.07 |
| ESR1 SRX20282946 | MCF-7 Breast | 320 / 23238 (1.4%) | 12211 / 232380 (5.3%) | −200.2 | −198.1 | 0.26 |
| FOXA1 SRX5323843 | MCF-7 Breast | 267 / 23238 (1.1%) | 11240 / 232380 (4.8%) | −199.9 | −197.8 | 0.24 |
| AR SRX1067066 | LHSAR Prostate | 1132 / 23238 (4.9%) | 24642 / 232380 (10.6%) | −199.5 | −197.4 | 0.46 |
| JUNB SRX10119383 | MCF 10A Breast | 364 / 23238 (1.6%) | 12957 / 232380 (5.6%) | −199.4 | −197.3 | 0.28 |
| FOXA1 SRX3923529 | ZR-75-1 Breast | 501 / 23238 (2.2%) | 15245 / 232380 (6.6%) | −199.2 | −197.1 | 0.33 |
| FOSL2 SRX5054309 | Neural progenitor cells Neural | 547 / 23238 (2.4%) | 15986 / 232380 (6.9%) | −199.2 | −197.1 | 0.34 |
| FOXA1 SRX15430993 | SK-BR-3 Breast | 490 / 23238 (2.1%) | 15057 / 232380 (6.5%) | −198.9 | −196.8 | 0.33 |
| FOXA1 SRX3931054 | MCF-7 Breast | 511 / 23238 (2.2%) | 15394 / 232380 (6.6%) | −198.8 | −196.7 | 0.33 |
| FOXA1 SRX3923533 | ZR-75-1 Breast | 589 / 23238 (2.5%) | 16633 / 232380 (7.2%) | −198.7 | −196.5 | 0.35 |
| FOXA2 SRX6441754 | CFPAC-1 Pancreas | 399 / 23238 (1.7%) | 13535 / 232380 (5.8%) | −198.7 | −196.5 | 0.29 |
| FOSL2 SRX10640864 | SK-MEL-147 Epidermis | 732 / 23238 (3.2%) | 18818 / 232380 (8.1%) | −198.3 | −196.2 | 0.39 |
| FOXA1 SRX028634 | MCF-7 Breast | 261 / 23238 (1.1%) | 11068 / 232380 (4.8%) | −198.0 | −195.9 | 0.24 |
| TAZ SRX14181208 | MSK-PCa3 Prostate | 575 / 23238 (2.5%) | 16387 / 232380 (7.1%) | −198.0 | −195.9 | 0.35 |
| FOXA2 SRX100448 | Hep G2 Liver | 606 / 23238 (2.6%) | 16847 / 232380 (7.2%) | −197.2 | −195.1 | 0.36 |
| TLE3 SRX4815192 | MCF-7 Breast | 499 / 23238 (2.1%) | 15138 / 232380 (6.5%) | −197.0 | −194.9 | 0.33 |
| FOXA1 SRX1787652 | MCF-7 Breast | 327 / 23238 (1.4%) | 12226 / 232380 (5.3%) | −196.8 | −194.7 | 0.27 |
| MEAF6 SRX10606585 | GIST-T1 Digestive tract | 2232 / 23238 (9.6%) | 10731 / 232380 (4.6%) | −196.5 | −194.4 | 2.08 |
| ESR1 SRX20282953 | MCF-7 Breast | 447 / 23238 (1.9%) | 14259 / 232380 (6.1%) | −196.2 | −194.1 | 0.31 |
| ESR1 SRX2881000 | MCF-7 Breast | 485 / 23238 (2.1%) | 14875 / 232380 (6.4%) | −196.0 | −193.9 | 0.33 |
| ESR1 SRX8537722 | MCF-7 Breast | 508 / 23238 (2.2%) | 15247 / 232380 (6.6%) | −196.0 | −193.9 | 0.33 |
| JUNB SRX10119384 | MCF 10A Breast | 324 / 23238 (1.4%) | 12138 / 232380 (5.2%) | −195.6 | −193.5 | 0.27 |
| BRPF1 SRX10606575 | GIST-T1 Digestive tract | 861 / 23238 (3.7%) | 2274 / 232380 (1.0%) | −195.6 | −193.5 | 3.79 |
| TP53 SRX2585782 | MDA-MB-231 Breast | 1012 / 23238 (4.4%) | 22794 / 232380 (9.8%) | −195.5 | −193.4 | 0.44 |
| SS18 SRX3468047 | Fibroblasts Others | 1374 / 23238 (5.9%) | 27780 / 232380 (12.0%) | −195.4 | −193.3 | 0.49 |
| FOXA1 SRX3923517 | MCF-7 Breast | 386 / 23238 (1.7%) | 13164 / 232380 (5.7%) | −194.1 | −192.0 | 0.29 |
| EP300 SRX176885 | MCF-7 Breast | 281 / 23238 (1.2%) | 11311 / 232380 (4.9%) | −193.9 | −191.8 | 0.25 |
| SOX13 SRX2636248 | Hep G2 Liver | 759 / 23238 (3.3%) | 19051 / 232380 (8.2%) | −193.8 | −191.7 | 0.40 |
| TRP47 SRX4548329 | THP-1 Blood | 3331 / 23238 (14.3%) | 18910 / 232380 (8.1%) | −193.7 | −191.6 | 1.76 |
| FOXA1 SRX028635 | MCF-7 Breast | 265 / 23238 (1.1%) | 11010 / 232380 (4.7%) | −193.7 | −191.6 | 0.24 |
| JUND SRX190357 | SK-N-SH Neural | 698 / 23238 (3.0%) | 18129 / 232380 (7.8%) | −193.6 | −191.5 | 0.39 |
| FOXA1 SRX1787651 | MCF-7 Breast | 308 / 23238 (1.3%) | 11783 / 232380 (5.1%) | −193.4 | −191.3 | 0.26 |
| TP53 SRX19538271 | U2OS Bone | 740 / 23238 (3.2%) | 1718 / 232380 (0.7%) | −193.1 | −191.0 | 4.31 |
| EP300 SRX2194265 | SUM 159PT Breast | 870 / 23238 (3.7%) | 20634 / 232380 (8.9%) | −192.5 | −190.4 | 0.42 |
| FOXA1 SRX3931055 | MCF-7 Breast | 468 / 23238 (2.0%) | 14472 / 232380 (6.2%) | −192.3 | −190.2 | 0.32 |
| PGR SRX1012655 | MCF-7 Breast | 352 / 23238 (1.5%) | 12516 / 232380 (5.4%) | −192.1 | −190.1 | 0.28 |
| EP300 SRX1012648 | MCF-7 Breast | 256 / 23238 (1.1%) | 10796 / 232380 (4.6%) | −192.1 | −190.0 | 0.24 |
| FOS SRX3322636 | MCF-7 Breast | 358 / 23238 (1.5%) | 12619 / 232380 (5.4%) | −192.0 | −189.9 | 0.28 |
| JUND SRX150408 | HeLa Uterus | 485 / 23238 (2.1%) | 14737 / 232380 (6.3%) | −191.9 | −189.8 | 0.33 |
| ESR1 SRX3110725 | MCF-7 Breast | 499 / 23238 (2.1%) | 14962 / 232380 (6.4%) | −191.8 | −189.8 | 0.33 |
| ESR1 SRX20282938 | MCF-7 Breast | 446 / 23238 (1.9%) | 14072 / 232380 (6.1%) | −191.1 | −189.1 | 0.32 |
| FOXA1 SRX1447317 | MCF-7 Breast | 355 / 23238 (1.5%) | 12525 / 232380 (5.4%) | −190.7 | −188.6 | 0.28 |
| ARID5B SRX3230377 | Hep G2 Liver | 1372 / 23238 (5.9%) | 27546 / 232380 (11.9%) | −190.7 | −188.6 | 0.50 |
| EP300 SRX2194266 | SUM 159PT Breast | 957 / 23238 (4.1%) | 21810 / 232380 (9.4%) | −190.5 | −188.5 | 0.44 |
| SMARCC1 SRX11379506 | Liposarcoma, Myxoid Adipocyte | 948 / 23238 (4.1%) | 21679 / 232380 (9.3%) | −190.5 | −188.4 | 0.44 |
| STAT5B SRX831881 | CD8+ T cells Blood | 305 / 23238 (1.3%) | 176 / 232380 (0.1%) | −189.8 | −187.8 | 17.33 |
| SS18 SRX10640843 | SK-MEL-147 Epidermis | 872 / 23238 (3.8%) | 20549 / 232380 (8.8%) | −189.5 | −187.5 | 0.42 |
| FOXA1 SRX8083099 | CAMA-1 Breast | 524 / 23238 (2.3%) | 15279 / 232380 (6.6%) | −189.5 | −187.4 | 0.34 |
| FOXA1 SRX3923516 | MCF-7 Breast | 400 / 23238 (1.7%) | 13243 / 232380 (5.7%) | −189.3 | −187.3 | 0.30 |
| FOXA2 SRX5504126 | CFPAC-1 Pancreas | 352 / 23238 (1.5%) | 12421 / 232380 (5.3%) | −189.1 | −187.1 | 0.28 |
| NANOG SRX10445309 | Neural crest cells Neural | 300 / 23238 (1.3%) | 11484 / 232380 (4.9%) | −188.5 | −186.4 | 0.26 |
| GATA3 SRX6712581 | MCF-7 Breast | 465 / 23238 (2.0%) | 14288 / 232380 (6.1%) | −188.3 | −186.3 | 0.33 |
| TLE3 SRX4815194 | SUM 149PT Breast | 425 / 23238 (1.8%) | 13618 / 232380 (5.9%) | −188.0 | −185.9 | 0.31 |
| SMARCC1 SRX11379504 | Liposarcoma, Myxoid Adipocyte | 1581 / 23238 (6.8%) | 30196 / 232380 (13.0%) | −187.8 | −185.8 | 0.52 |
| DNA-RNA hybrid SRX20083259 | SH-SY5Y Neural | 1034 / 23238 (4.4%) | 3267 / 232380 (1.4%) | −187.8 | −185.8 | 3.16 |
| CNOT3 SRX886405 | HCT 116 Digestive tract | 2419 / 23238 (10.4%) | 12272 / 232380 (5.3%) | −187.7 | −185.7 | 1.97 |
| NR2F2 SRX190293 | MCF-7 Breast | 600 / 23238 (2.6%) | 16410 / 232380 (7.1%) | −187.7 | −185.7 | 0.37 |
| GATAD2A SRX2636506 | Hep G2 Liver | 722 / 23238 (3.1%) | 18263 / 232380 (7.9%) | −187.6 | −185.5 | 0.40 |
| ESR1 SRX10365533 | MCF-7 Breast | 263 / 23238 (1.1%) | 10780 / 232380 (4.6%) | −187.4 | −185.4 | 0.24 |
| 5-mC SRX882965 | LNCAP Prostate | 2932 / 23238 (12.6%) | 16070 / 232380 (6.9%) | −187.2 | −185.2 | 1.82 |
| SMARCC1 SRX11379505 | Liposarcoma, Myxoid Adipocyte | 981 / 23238 (4.2%) | 22016 / 232380 (9.5%) | −187.2 | −185.1 | 0.45 |
| ESR1 SRX4451213 | MCF-7 Breast | 579 / 23238 (2.5%) | 16065 / 232380 (6.9%) | −187.1 | −185.1 | 0.36 |
| FOXA1 SRX1787655 | MCF-7 Breast | 279 / 23238 (1.2%) | 11065 / 232380 (4.8%) | −187.1 | −185.0 | 0.25 |
| ESR1 SRX330070 | MCF-7 Breast | 291 / 23238 (1.3%) | 11281 / 232380 (4.9%) | −187.1 | −185.0 | 0.26 |
| ERG SRX026653 | CD34 Hematopoietic stem cells Blood | 2072 / 23238 (8.9%) | 9839 / 232380 (4.2%) | −186.9 | −184.9 | 2.11 |
| ESR1 SRX330069 | MCF-7 Breast | 348 / 23238 (1.5%) | 12278 / 232380 (5.3%) | −186.9 | −184.8 | 0.28 |
| Epitope tags SRX10549778 | K-562 Blood | 1415 / 23238 (6.1%) | 5512 / 232380 (2.4%) | −186.8 | −184.8 | 2.57 |
| EP300 SRX100540 | SK-N-SH Neural | 819 / 23238 (3.5%) | 19668 / 232380 (8.5%) | −186.7 | −184.7 | 0.42 |
| SSRP1 SRX3436567 | HT-1080 Bone | 492 / 23238 (2.1%) | 737 / 232380 (0.3%) | −186.6 | −184.6 | 6.68 |
| SMARCC1 SRX11379517 | Liposarcoma, Myxoid Adipocyte | 473 / 23238 (2.0%) | 14358 / 232380 (6.2%) | −186.6 | −184.6 | 0.33 |
| ESR1 SRX1012632 | MCF-7 Breast | 276 / 23238 (1.2%) | 10988 / 232380 (4.7%) | −186.4 | −184.4 | 0.25 |
| ARID1A SRX5089385 | MCF-7 Breast | 422 / 23238 (1.8%) | 13515 / 232380 (5.8%) | −186.4 | −184.4 | 0.31 |
| ESR1 SRX1012629 | MCF-7 Breast | 355 / 23238 (1.5%) | 12370 / 232380 (5.3%) | −186.0 | −184.0 | 0.29 |
| MEAF6 SRX10606584 | GIST-T1 Digestive tract | 1994 / 23238 (8.6%) | 9327 / 232380 (4.0%) | −185.7 | −183.7 | 2.14 |
| FOXA1 SRX3923518 | MCF-7 Breast | 388 / 23238 (1.7%) | 12921 / 232380 (5.6%) | −185.6 | −183.6 | 0.30 |
| ESR1 SRX2943589 | MCF-7 Breast | 289 / 23238 (1.2%) | 11193 / 232380 (4.8%) | −185.5 | −183.4 | 0.26 |
| DNA-RNA hybrid SRX20083265 | SH-SY5Y Neural | 976 / 23238 (4.2%) | 2982 / 232380 (1.3%) | −185.4 | −183.4 | 3.27 |
| NR3C1 SRX9298951 | Lung cancer cell line Lung | 354 / 23238 (1.5%) | 12333 / 232380 (5.3%) | −185.3 | −183.3 | 0.29 |
| ARID5B SRX10475139 | Hep G2 Liver | 616 / 23238 (2.7%) | 16566 / 232380 (7.1%) | −185.2 | −183.2 | 0.37 |
| FOXA1 SRX5124035 | 22Rv1 Prostate | 727 / 23238 (3.1%) | 18246 / 232380 (7.9%) | −185.1 | −183.1 | 0.40 |
| NR3C1 SRX17639412 | A549 Lung | 630 / 23238 (2.7%) | 16765 / 232380 (7.2%) | −184.8 | −182.7 | 0.38 |
| ESR1 SRX2912055 | MCF-7 Breast | 212 / 23238 (0.9%) | 9730 / 232380 (4.2%) | −184.5 | −182.5 | 0.22 |
| NR3C1 SRX8520809 | SUM 159PT Breast | 497 / 23238 (2.1%) | 14673 / 232380 (6.3%) | −184.4 | −182.4 | 0.34 |
| PROX1 SRX3230397 | Hep G2 Liver | 409 / 23238 (1.8%) | 13230 / 232380 (5.7%) | −184.3 | −182.3 | 0.31 |
| TRIM25 SRX1660873 | Breast cancer cells Breast | 2443 / 23238 (10.5%) | 12544 / 232380 (5.4%) | −183.9 | −181.9 | 1.95 |
| WWTR1 SRX10119378 | MCF 10A Breast | 618 / 23238 (2.7%) | 16552 / 232380 (7.1%) | −183.9 | −181.9 | 0.37 |
| NANOG SRX10448024 | hESC H1 Pluripotent stem cell | 1929 / 23238 (8.3%) | 34485 / 232380 (14.8%) | −183.7 | −181.7 | 0.56 |
| ESR1 SRX10365558 | MCF-7 Breast | 387 / 23238 (1.7%) | 12840 / 232380 (5.5%) | −183.7 | −181.7 | 0.30 |
| JUN SRX2355072 | HAEC Cardiovascular | 750 / 23238 (3.2%) | 18531 / 232380 (8.0%) | −183.6 | −181.6 | 0.40 |
| SMARCC1 SRX11379511 | Liposarcoma, Myxoid Adipocyte | 766 / 23238 (3.3%) | 18763 / 232380 (8.1%) | −183.5 | −181.5 | 0.41 |
| FOSL2 SRX190204 | A549 Lung | 564 / 23238 (2.4%) | 15682 / 232380 (6.7%) | −183.0 | −181.0 | 0.36 |
| FOXA1 SRX3923532 | ZR-75-1 Breast | 377 / 23238 (1.6%) | 12635 / 232380 (5.4%) | −182.7 | −180.7 | 0.30 |
| SREBF2 SRX5359048 | HCC70 Breast | 2126 / 23238 (9.1%) | 10316 / 232380 (4.4%) | −182.6 | −180.6 | 2.06 |
| RNF2 SRX18954719 | SCC-25 Others | 772 / 23238 (3.3%) | 18811 / 232380 (8.1%) | −182.5 | −180.5 | 0.41 |
| FOXA1 SRX190181 | A549 Lung | 409 / 23238 (1.8%) | 13163 / 232380 (5.7%) | −182.4 | −180.4 | 0.31 |
| FOXA1 SRX1961157 | T-47D Breast | 623 / 23238 (2.7%) | 16569 / 232380 (7.1%) | −182.4 | −180.4 | 0.38 |
| AR SRX9109113 | MDA-MB-453 Breast | 1087 / 23238 (4.7%) | 23299 / 232380 (10.0%) | −182.3 | −180.3 | 0.47 |
| FOXA1 SRX11222438 | MCF-7 Breast | 305 / 23238 (1.3%) | 11373 / 232380 (4.9%) | −182.1 | −180.1 | 0.27 |
| CEBPA SRX2630241 | Hep G2 Liver | 702 / 23238 (3.0%) | 17756 / 232380 (7.6%) | −182.0 | −180.1 | 0.40 |
| ZEB1 SRX13298925 | MCF-7 Breast | 353 / 23238 (1.5%) | 12206 / 232380 (5.3%) | −182.0 | −180.0 | 0.29 |
| ESR1 SRX20282959 | MCF-7 Breast | 234 / 23238 (1.0%) | 10067 / 232380 (4.3%) | −181.8 | −179.8 | 0.23 |
| FOS SRX070879 | HUVEC Cardiovascular | 615 / 23238 (2.6%) | 16418 / 232380 (7.1%) | −181.5 | −179.5 | 0.37 |
| TAL1 SRX393518 | Primary endothelial cells Cardiovascular | 817 / 23238 (3.5%) | 19434 / 232380 (8.4%) | −181.5 | −179.5 | 0.42 |
| FOSL1 SRX190212 | HCT 116 Digestive tract | 664 / 23238 (2.9%) | 17157 / 232380 (7.4%) | −181.4 | −179.4 | 0.39 |
| KMT2A SRX2323891 | 293 Kidney | 1238 / 23238 (5.3%) | 4530 / 232380 (1.9%) | −181.1 | −179.2 | 2.73 |
| FOXA1 SRX15430999 | T-47D Breast | 639 / 23238 (2.7%) | 16765 / 232380 (7.2%) | −181.0 | −179.0 | 0.38 |
| MAML1 SRX8970969 | Squamous cell carcinoma Others | 562 / 23238 (2.4%) | 15572 / 232380 (6.7%) | −180.9 | −178.9 | 0.36 |
| ESR1 SRX3123829 | MCF-7 Breast | 335 / 23238 (1.4%) | 11857 / 232380 (5.1%) | −180.8 | −178.9 | 0.28 |
| SMARCA4 SRX8588624 | Pulmonary artery endothelial cells Cardiovascular | 1002 / 23238 (4.3%) | 22040 / 232380 (9.5%) | −180.5 | −178.5 | 0.45 |
| JUN SRX6582171 | GM07492 Others | 1094 / 23238 (4.7%) | 23322 / 232380 (10.0%) | −180.4 | −178.4 | 0.47 |
| EP300 SRX1012644 | MCF-7 Breast | 258 / 23238 (1.1%) | 10470 / 232380 (4.5%) | −180.4 | −178.4 | 0.25 |
| FOXA1 SRX3923528 | ZR-75-1 Breast | 386 / 23238 (1.7%) | 12699 / 232380 (5.5%) | −180.1 | −178.1 | 0.30 |
| FOXA1 SRX100477 | Hep G2 Liver | 659 / 23238 (2.8%) | 17032 / 232380 (7.3%) | −180.0 | −178.1 | 0.39 |
| NANOG SRX017277 | hESC H1 Pluripotent stem cell | 220 / 23238 (0.9%) | 9751 / 232380 (4.2%) | −179.9 | −178.0 | 0.23 |
| FOXA1 SRX5323829 | T-47D Breast | 323 / 23238 (1.4%) | 11619 / 232380 (5.0%) | −179.9 | −178.0 | 0.28 |
| FOS SRX3322637 | MCF-7 Breast | 305 / 23238 (1.3%) | 11304 / 232380 (4.9%) | −179.9 | −178.0 | 0.27 |
| ESR1 SRX1012633 | MCF-7 Breast | 298 / 23238 (1.3%) | 11175 / 232380 (4.8%) | −179.9 | −177.9 | 0.27 |
| ESR1 SRX1531796 | MCF-7 Breast | 309 / 23238 (1.3%) | 11364 / 232380 (4.9%) | −179.6 | −177.6 | 0.27 |
| TEAD4 SRX10640862 | SK-MEL-147 Epidermis | 889 / 23238 (3.8%) | 20390 / 232380 (8.8%) | −179.3 | −177.3 | 0.44 |
| KDM1A SRX10637290 | MDA-MB-231 Breast | 742 / 23238 (3.2%) | 18243 / 232380 (7.9%) | −179.2 | −177.3 | 0.41 |
| FOXA1 SRX3923519 | MCF-7 Breast | 355 / 23238 (1.5%) | 12137 / 232380 (5.2%) | −178.9 | −177.0 | 0.29 |
| NKX2-1 SRX366169 | NCI-H441 Lung | 694 / 23238 (3.0%) | 17506 / 232380 (7.5%) | −178.6 | −176.7 | 0.40 |
| FOXA1 SRX8083098 | CAMA-1 Breast | 475 / 23238 (2.0%) | 14099 / 232380 (6.1%) | −178.1 | −176.2 | 0.34 |
| SMARCA4 SRX027488 | hESC H9 Pluripotent stem cell | 156 / 23238 (0.7%) | 8428 / 232380 (3.6%) | −177.9 | −175.9 | 0.19 |
| FOXA1 SRX3931033 | MCF-7 Breast | 369 / 23238 (1.6%) | 12336 / 232380 (5.3%) | −177.8 | −175.8 | 0.30 |
| FOS SRX150664 | HUVEC Cardiovascular | 769 / 23238 (3.3%) | 18584 / 232380 (8.0%) | −177.7 | −175.7 | 0.41 |
| FOXA1 SRX1161203 | T-47D Breast | 421 / 23238 (1.8%) | 13198 / 232380 (5.7%) | −177.6 | −175.6 | 0.32 |
| FOXA1 SRX190282 | A549 Lung | 402 / 23238 (1.7%) | 12879 / 232380 (5.5%) | −177.4 | −175.5 | 0.31 |
| CEBPB SRX11379528 | Liposarcoma, Myxoid Adipocyte | 1292 / 23238 (5.6%) | 25874 / 232380 (11.1%) | −177.0 | −175.1 | 0.50 |
| ESR1 SRX5534832 | MCF-7 Breast | 528 / 23238 (2.3%) | 14897 / 232380 (6.4%) | −176.9 | −175.0 | 0.35 |
| ESR1 SRX1469949 | MCF-7 Breast | 335 / 23238 (1.4%) | 11729 / 232380 (5.0%) | −176.8 | −174.9 | 0.29 |
| SMARCA4 SRX5075175 | Neural progenitor cells Neural | 870 / 23238 (3.7%) | 20009 / 232380 (8.6%) | −176.7 | −174.7 | 0.43 |
| NR1H3 SRX1538763 | HT-29 Digestive tract | 554 / 23238 (2.4%) | 15287 / 232380 (6.6%) | −176.4 | −174.5 | 0.36 |
| SS18 SRX10640841 | SK-MEL-147 Epidermis | 838 / 23238 (3.6%) | 19540 / 232380 (8.4%) | −176.4 | −174.4 | 0.43 |
| JADE3 DRX234809 | 293 Kidney | 1279 / 23238 (5.5%) | 4852 / 232380 (2.1%) | −176.4 | −174.4 | 2.64 |
| SOX2 SRX2731713 | Lung cancer cell line Lung | 267 / 23238 (1.1%) | 132 / 232380 (0.1%) | −175.4 | −173.5 | 20.23 |
| MEN1 SRX11712604 | K-562 Blood | 1775 / 23238 (7.6%) | 8065 / 232380 (3.5%) | −175.3 | −173.4 | 2.20 |
| SP1 SRX190358 | HCT 116 Digestive tract | 894 / 23238 (3.8%) | 20290 / 232380 (8.7%) | −175.1 | −173.1 | 0.44 |
| MITF SRX1555436 | 501A Epidermis | 2460 / 23238 (10.6%) | 12910 / 232380 (5.6%) | −174.9 | −173.0 | 1.91 |
| CXXC1 SRX1424886 | SEM Blood | 1818 / 23238 (7.8%) | 8372 / 232380 (3.6%) | −174.6 | −172.6 | 2.17 |
| TFAP2C SRX018833 | MCF-7 Breast | 537 / 23238 (2.3%) | 14954 / 232380 (6.4%) | −174.5 | −172.6 | 0.36 |
| ESR1 SRX5323873 | MCF-7 Breast | 726 / 23238 (3.1%) | 17827 / 232380 (7.7%) | −174.5 | −172.6 | 0.41 |
| EP300 SRX1012643 | MCF-7 Breast | 211 / 23238 (0.9%) | 9411 / 232380 (4.0%) | −174.4 | −172.5 | 0.22 |
| JUN SRX6582172 | Fibroblasts Others | 775 / 23238 (3.3%) | 18537 / 232380 (8.0%) | −174.2 | −172.3 | 0.42 |
| EP300 SRX2671792 | Cardiac progenitor cells Cardiovascular | 446 / 23238 (1.9%) | 13491 / 232380 (5.8%) | −174.2 | −172.2 | 0.33 |
| FOXA1 SRX13814018 | 5637 Others | 374 / 23238 (1.6%) | 12300 / 232380 (5.3%) | −174.1 | −172.2 | 0.30 |
| ESR1 SRX8537723 | MCF-7 Breast | 479 / 23238 (2.1%) | 14016 / 232380 (6.0%) | −173.9 | −172.0 | 0.34 |
| FOXA1 SRX1961158 | T-47D Breast | 585 / 23238 (2.5%) | 15673 / 232380 (6.7%) | −173.8 | −171.9 | 0.37 |
| RNF2 SRX18954704 | FaDu Others | 1360 / 23238 (5.9%) | 26644 / 232380 (11.5%) | −173.8 | −171.9 | 0.51 |
| HMG20A SRX2630163 | Hep G2 Liver | 336 / 23238 (1.4%) | 11637 / 232380 (5.0%) | −173.6 | −171.6 | 0.29 |
| BMI1 SRX7196715 | SU-DIPG-IV Neural | 2261 / 23238 (9.7%) | 11501 / 232380 (4.9%) | −173.5 | −171.5 | 1.97 |
| EP300 SRX176883 | MCF-7 Breast | 279 / 23238 (1.2%) | 10633 / 232380 (4.6%) | −173.4 | −171.4 | 0.26 |
| JUN SRX2355073 | HAEC Cardiovascular | 741 / 23238 (3.2%) | 18006 / 232380 (7.7%) | −173.3 | −171.4 | 0.41 |
| TFAP2C SRX128099 | MCF-7 Breast | 539 / 23238 (2.3%) | 14933 / 232380 (6.4%) | −173.1 | −171.2 | 0.36 |
| FOXA1 SRX3923531 | ZR-75-1 Breast | 336 / 23238 (1.4%) | 11616 / 232380 (5.0%) | −173.0 | −171.1 | 0.29 |
| STAT1 SRX23678708 | K-562 Blood | 1914 / 23238 (8.2%) | 9070 / 232380 (3.9%) | −172.8 | −170.9 | 2.11 |
| FOS SRX7760064 | CFPAC-1 Pancreas | 484 / 23238 (2.1%) | 14040 / 232380 (6.0%) | −172.3 | −170.4 | 0.34 |
| DNA-RNA hybrid SRX21658480 | U2OS Bone | 651 / 23238 (2.8%) | 1493 / 232380 (0.6%) | −171.9 | −170.0 | 4.36 |
| NR3C1 SRX19024870 | MCF-7 Breast | 195 / 23238 (0.8%) | 9020 / 232380 (3.9%) | −171.7 | −169.8 | 0.22 |
| MEAF6 SRX10606586 | GIST-T1 Digestive tract | 1542 / 23238 (6.6%) | 6595 / 232380 (2.8%) | −171.6 | −169.7 | 2.34 |
| ESR1 SRX11120903 | MCF-7 Breast | 518 / 23238 (2.2%) | 14547 / 232380 (6.3%) | −171.5 | −169.6 | 0.36 |
| FOXA1 SRX5323845 | MCF-7 Breast | 216 / 23238 (0.9%) | 9412 / 232380 (4.1%) | −171.3 | −169.4 | 0.23 |
| FOXA1 SRX3931056 | MCF-7 Breast | 349 / 23238 (1.5%) | 11784 / 232380 (5.1%) | −171.3 | −169.4 | 0.30 |
| NR3C1 SRX10976921 | A549 Lung | 421 / 23238 (1.8%) | 12979 / 232380 (5.6%) | −171.2 | −169.2 | 0.32 |
| ESR1 SRX4451212 | MCF-7 Breast | 572 / 23238 (2.5%) | 15367 / 232380 (6.6%) | −170.9 | −169.0 | 0.37 |
| FOXA1 SRX3923530 | ZR-75-1 Breast | 392 / 23238 (1.7%) | 12489 / 232380 (5.4%) | −170.8 | −168.9 | 0.31 |
| CEBPB SRX190345 | MCF-7 Breast | 464 / 23238 (2.0%) | 13662 / 232380 (5.9%) | −170.7 | −168.8 | 0.34 |
| GATA3 SRX100559 | T-47D Breast | 660 / 23238 (2.8%) | 16697 / 232380 (7.2%) | −170.6 | −168.7 | 0.40 |
| NR3C1 SRX19024866 | MCF-7 Breast | 209 / 23238 (0.9%) | 9255 / 232380 (4.0%) | −170.6 | −168.7 | 0.23 |
| FOXA1 SRX5203303 | MCF-7 Breast | 206 / 23238 (0.9%) | 9188 / 232380 (4.0%) | −170.2 | −168.3 | 0.22 |
| ARID1A SRX5089391 | MCF-7 Breast | 342 / 23238 (1.5%) | 11622 / 232380 (5.0%) | −170.0 | −168.1 | 0.29 |
| ARID1A SRX5089382 | MCF-7 Breast | 429 / 23238 (1.8%) | 13063 / 232380 (5.6%) | −169.8 | −167.9 | 0.33 |
| CTNNB1 SRX833403 | hESC H1 Pluripotent stem cell | 173 / 23238 (0.7%) | 8524 / 232380 (3.7%) | −169.5 | −167.6 | 0.20 |
| ARID1A SRX5089388 | MCF-7 Breast | 307 / 23238 (1.3%) | 11000 / 232380 (4.7%) | −169.4 | −167.5 | 0.28 |
| FOXA1 SRX1161205 | T-47D Breast | 321 / 23238 (1.4%) | 11242 / 232380 (4.8%) | −169.3 | −167.4 | 0.29 |
| FOXA1 SRX1447316 | MCF-7 Breast | 253 / 23238 (1.1%) | 10033 / 232380 (4.3%) | −169.3 | −167.4 | 0.25 |
| SOX5 SRX2636544 | Hep G2 Liver | 600 / 23238 (2.6%) | 15734 / 232380 (6.8%) | −169.1 | −167.2 | 0.38 |
| FOXA1 SRX3923515 | MCF-7 Breast | 339 / 23238 (1.5%) | 11539 / 232380 (5.0%) | −169.1 | −167.2 | 0.29 |
| MED1 SRX4937338 | HCT 116 Digestive tract | 1756 / 23238 (7.6%) | 8071 / 232380 (3.5%) | −169.1 | −167.2 | 2.18 |
| FOXL2 SRX6957431 | KGN Gonad | 1333 / 23238 (5.7%) | 26057 / 232380 (11.2%) | −168.8 | −166.9 | 0.51 |
| SMARCA4 SRX5982340 | A549 Lung | 244 / 23238 (1.1%) | 9851 / 232380 (4.2%) | −168.7 | −166.8 | 0.25 |
| MECOM SRX23677884 | HNT-34 Blood | 2154 / 23238 (9.3%) | 10860 / 232380 (4.7%) | −168.6 | −166.7 | 1.98 |
| OTX2 SRX702045 | hESC HUES64 Pluripotent stem cell | 459 / 23238 (2.0%) | 13494 / 232380 (5.8%) | −168.2 | −166.3 | 0.34 |
| ESR1 SRX330068 | MCF-7 Breast | 292 / 23238 (1.3%) | 10693 / 232380 (4.6%) | −168.1 | −166.2 | 0.27 |
| GATAD2A SRX2636507 | Hep G2 Liver | 648 / 23238 (2.8%) | 16421 / 232380 (7.1%) | −168.1 | −166.2 | 0.39 |
| NR3C1 SRX8520802 | HCC1187 Breast | 450 / 23238 (1.9%) | 13345 / 232380 (5.7%) | −168.0 | −166.2 | 0.34 |
| EP300 SRX100544 | Hep G2 Liver | 460 / 23238 (2.0%) | 13499 / 232380 (5.8%) | −168.0 | −166.1 | 0.34 |
| ESR1 SRX5323871 | MCF-7 Breast | 663 / 23238 (2.9%) | 16639 / 232380 (7.2%) | −167.9 | −166.0 | 0.40 |
| MECOM SRX23677885 | HNT-34 Blood | 2178 / 23238 (9.4%) | 11052 / 232380 (4.8%) | −167.8 | −166.0 | 1.97 |
| ESR1 SRX1469951 | MCF-7 Breast | 318 / 23238 (1.4%) | 11132 / 232380 (4.8%) | −167.6 | −165.8 | 0.29 |
| ESR1 SRX2897220 | Breast cancer cells Breast | 1942 / 23238 (8.4%) | 9387 / 232380 (4.0%) | −167.5 | −165.7 | 2.07 |
| FOXA1 SRX6878603 | LNCAP Prostate | 665 / 23238 (2.9%) | 16648 / 232380 (7.2%) | −167.5 | −165.6 | 0.40 |
| YAP1 SRX10119388 | MDA-MB-231 Breast | 427 / 23238 (1.8%) | 12951 / 232380 (5.6%) | −167.4 | −165.5 | 0.33 |
| TEAD1 SRX14688734 | HUVEC Cardiovascular | 525 / 23238 (2.3%) | 14508 / 232380 (6.2%) | −167.3 | −165.4 | 0.36 |
| JUNB SRX10119385 | MCF 10A Breast | 276 / 23238 (1.2%) | 10380 / 232380 (4.5%) | −167.2 | −165.3 | 0.27 |
| TEAD4 SRX10640861 | SK-MEL-147 Epidermis | 652 / 23238 (2.8%) | 16442 / 232380 (7.1%) | −167.1 | −165.3 | 0.40 |
| SMAD3 SRX366168 | NCI-H441 Lung | 529 / 23238 (2.3%) | 14554 / 232380 (6.3%) | −166.9 | −165.1 | 0.36 |
| NANOG SRX3288567 | hESC H9 Pluripotent stem cell | 219 / 23238 (0.9%) | 9332 / 232380 (4.0%) | −166.9 | −165.0 | 0.23 |
| ESR1 SRX1012630 | MCF-7 Breast | 237 / 23238 (1.0%) | 9664 / 232380 (4.2%) | −166.9 | −165.0 | 0.25 |
| FOXA1 SRX15430987 | MDA-MB-453 Breast | 873 / 23238 (3.8%) | 19647 / 232380 (8.5%) | −166.6 | −164.7 | 0.44 |
| ESR1 SRX5323878 | MCF-7 Breast | 613 / 23238 (2.6%) | 15826 / 232380 (6.8%) | −166.4 | −164.5 | 0.39 |
| NR3C1 SRX1161181 | ZR-75-1 Breast | 174 / 23238 (0.7%) | 8453 / 232380 (3.6%) | −166.3 | −164.4 | 0.21 |
| FOXA1 SRX1787654 | MCF-7 Breast | 226 / 23238 (1.0%) | 9436 / 232380 (4.1%) | −166.1 | −164.2 | 0.24 |
| EP300 SRX2671820 | iPS cells Pluripotent stem cell | 143 / 23238 (0.6%) | 7810 / 232380 (3.4%) | −165.8 | −163.9 | 0.18 |
| NANOG SRX5286326 | hESC WIBR2 Pluripotent stem cell | 512 / 23238 (2.2%) | 14245 / 232380 (6.1%) | −165.7 | −163.9 | 0.36 |
| BMI1 SRX7196721 | SF8628 Neural | 2117 / 23238 (9.1%) | 10666 / 232380 (4.6%) | −165.7 | −163.9 | 1.98 |
| ESR1 SRX1161186 | ZR-75-1 Breast | 198 / 23238 (0.9%) | 8894 / 232380 (3.8%) | −165.6 | −163.7 | 0.22 |
| KAT7 DRX234808 | 293 Kidney | 943 / 23238 (4.1%) | 3053 / 232380 (1.3%) | −165.3 | −163.5 | 3.09 |
| JUND SRX699738 | HCASMC Cardiovascular | 838 / 23238 (3.6%) | 19091 / 232380 (8.2%) | −165.2 | −163.3 | 0.44 |
| NR3C1 SRX10977357 | A549 Lung | 379 / 23238 (1.6%) | 12085 / 232380 (5.2%) | −165.1 | −163.3 | 0.31 |
| ESR1 SRX792933 | LY2 Breast | 506 / 23238 (2.2%) | 14125 / 232380 (6.1%) | −165.0 | −163.1 | 0.36 |
| FOXA1 SRX5323830 | T-47D Breast | 365 / 23238 (1.6%) | 11841 / 232380 (5.1%) | −165.0 | −163.1 | 0.31 |
| FOXA2 SRX6441751 | CFPAC-1 Pancreas | 278 / 23238 (1.2%) | 10343 / 232380 (4.5%) | −164.9 | −163.1 | 0.27 |
| GATA3 SRX5457550 | MCF-7 Breast | 694 / 23238 (3.0%) | 16982 / 232380 (7.3%) | −164.9 | −163.0 | 0.41 |
| SMAD3 SRX11483609 | Keratinocytes Epidermis | 858 / 23238 (3.7%) | 19357 / 232380 (8.3%) | −164.7 | −162.8 | 0.44 |
| FOXA2 SRX10475773 | Hep G2 Liver | 739 / 23238 (3.2%) | 17634 / 232380 (7.6%) | −164.6 | −162.7 | 0.42 |
| Epitope tags SRX8080558 | Mammary gland adenocarcinoma Breast | 230 / 23238 (1.0%) | 9460 / 232380 (4.1%) | −164.4 | −162.6 | 0.24 |
| ESR1 SRX5534831 | MCF-7 Breast | 478 / 23238 (2.1%) | 13660 / 232380 (5.9%) | −164.4 | −162.5 | 0.35 |
| ING2 SRX286201 | RKO Digestive tract | 1748 / 23238 (7.5%) | 8118 / 232380 (3.5%) | −164.4 | −162.5 | 2.15 |
| FOXA2 SRX11650948 | hESC derived pancreatic cells Pluripotent stem cell | 528 / 23238 (2.3%) | 14444 / 232380 (6.2%) | −164.3 | −162.5 | 0.37 |
| FOXA1 SRX5124036 | 22Rv1 Prostate | 635 / 23238 (2.7%) | 16077 / 232380 (6.9%) | −164.2 | −162.4 | 0.39 |
| VGLL1 SRX18013277 | FULVR Breast | 270 / 23238 (1.2%) | 10177 / 232380 (4.4%) | −164.2 | −162.4 | 0.27 |
| FOXA1 SRX3931032 | MCF-7 Breast | 357 / 23238 (1.5%) | 11681 / 232380 (5.0%) | −164.2 | −162.4 | 0.31 |
| FOXA1 SRX5323846 | MCF-7 Breast | 233 / 23238 (1.0%) | 9504 / 232380 (4.1%) | −164.1 | −162.2 | 0.25 |
| EP300 SRX10976215 | A549 Lung | 568 / 23238 (2.4%) | 15046 / 232380 (6.5%) | −163.9 | −162.0 | 0.38 |
| MECOM SRX23677896 | HNT-34 Blood | 2640 / 23238 (11.4%) | 14567 / 232380 (6.3%) | −163.9 | −162.0 | 1.81 |
| ESR1 SRX10365534 | MCF-7 Breast | 186 / 23238 (0.8%) | 8605 / 232380 (3.7%) | −163.5 | −161.7 | 0.22 |
| ATF1 SRX11470446 | Mesenchymal stem cells Others | 1459 / 23238 (6.3%) | 27476 / 232380 (11.8%) | −163.5 | −161.7 | 0.53 |
| DNA-RNA hybrid SRX20083264 | SH-SY5Y Neural | 894 / 23238 (3.8%) | 2807 / 232380 (1.2%) | −163.5 | −161.6 | 3.18 |
| ESR1 SRX2513521 | MCF-7 Breast | 297 / 23238 (1.3%) | 10632 / 232380 (4.6%) | −163.4 | −161.6 | 0.28 |
| CDK9 SRX7366783 | MCF-7 Breast | 274 / 23238 (1.2%) | 177 / 232380 (0.1%) | −163.4 | −161.6 | 15.48 |
| CDYL2 SRX8321653 | MCF-7 Breast | 2247 / 23238 (9.7%) | 11668 / 232380 (5.0%) | −163.4 | −161.6 | 1.93 |
| NR3C1 SRX10977372 | A549 Lung | 356 / 23238 (1.5%) | 11639 / 232380 (5.0%) | −163.4 | −161.6 | 0.31 |
| AR SRX15946405 | MDA-MB-453 Breast | 397 / 23238 (1.7%) | 12318 / 232380 (5.3%) | −163.3 | −161.4 | 0.32 |
| MYC SRX150570 | MCF 10A Breast | 416 / 23238 (1.8%) | 12616 / 232380 (5.4%) | −163.0 | −161.1 | 0.33 |
| MED1 SRX4937342 | HCT 116 Digestive tract | 1656 / 23238 (7.1%) | 7528 / 232380 (3.2%) | −162.9 | −161.1 | 2.20 |
| EP300 SRX2671813 | Fibroblasts Others | 527 / 23238 (2.3%) | 14375 / 232380 (6.2%) | −162.8 | −160.9 | 0.37 |
| JUN SRX9350646 | Melanoma cell line Epidermis | 805 / 23238 (3.5%) | 18511 / 232380 (8.0%) | −162.6 | −160.7 | 0.43 |
| AR SRX11149848 | MDA-MB-453 Breast | 399 / 23238 (1.7%) | 12322 / 232380 (5.3%) | −162.4 | −160.6 | 0.32 |
| FOXA2 SRX2368889 | Ker-CT Epidermis | 504 / 23238 (2.2%) | 13999 / 232380 (6.0%) | −162.4 | −160.5 | 0.36 |
| NR3C1 SRX18884271 | A549 Lung | 331 / 23238 (1.4%) | 11179 / 232380 (4.8%) | −162.2 | −160.4 | 0.30 |
| ZEB1 SRX13298924 | MCF-7 Breast | 306 / 23238 (1.3%) | 10738 / 232380 (4.6%) | −161.9 | −160.1 | 0.28 |
| NFIL3 SRX2630334 | Hep G2 Liver | 501 / 23238 (2.2%) | 13935 / 232380 (6.0%) | −161.8 | −160.0 | 0.36 |
| EP300 SRX2671806 | iPS cells Pluripotent stem cell | 128 / 23238 (0.6%) | 7384 / 232380 (3.2%) | −161.8 | −160.0 | 0.17 |
| ESR1 SRX2881001 | MCF-7 Breast | 347 / 23238 (1.5%) | 11433 / 232380 (4.9%) | −161.7 | −159.9 | 0.30 |
| YAP1 SRX10119387 | MDA-MB-231 Breast | 459 / 23238 (2.0%) | 13265 / 232380 (5.7%) | −161.7 | −159.9 | 0.35 |
| YY1 SRX13585223 | NCCIT Pluripotent stem cell | 1371 / 23238 (5.9%) | 5681 / 232380 (2.4%) | −161.7 | −159.8 | 2.41 |
| FOXA1 SRX1389379 | CFPAC-1 Pancreas | 424 / 23238 (1.8%) | 12696 / 232380 (5.5%) | −161.5 | −159.7 | 0.33 |
| FOXA1 SRX5203307 | MCF-7 Breast | 188 / 23238 (0.8%) | 8576 / 232380 (3.7%) | −161.4 | −159.6 | 0.22 |
| ZEB1 SRX13298923 | MCF-7 Breast | 269 / 23238 (1.2%) | 10069 / 232380 (4.3%) | −161.4 | −159.6 | 0.27 |
| RXRB SRX2636027 | Hep G2 Liver | 667 / 23238 (2.9%) | 16448 / 232380 (7.1%) | −161.4 | −159.6 | 0.41 |
| Epitope tags SRX5877912 | U2OS Bone | 3147 / 23238 (13.5%) | 48111 / 232380 (20.7%) | −161.3 | −159.5 | 0.65 |
| ESR1 SRX2513517 | MCF-7 Breast | 429 / 23238 (1.8%) | 12762 / 232380 (5.5%) | −161.0 | −159.2 | 0.34 |
| CBX3 SRX190214 | HCT 116 Digestive tract | 1051 / 23238 (4.5%) | 21899 / 232380 (9.4%) | −161.0 | −159.1 | 0.48 |
| NR3C1 SRX18884260 | A549 Lung | 360 / 23238 (1.5%) | 11618 / 232380 (5.0%) | −160.8 | −159.0 | 0.31 |
| ESR1 SRX5323877 | MCF-7 Breast | 489 / 23238 (2.1%) | 13708 / 232380 (5.9%) | −160.8 | −159.0 | 0.36 |
| EP300 SRX717859 | HeLa Uterus | 336 / 23238 (1.4%) | 11206 / 232380 (4.8%) | −160.5 | −158.7 | 0.30 |
| EP300 SRX717860 | HeLa Uterus | 404 / 23238 (1.7%) | 12332 / 232380 (5.3%) | −160.4 | −158.6 | 0.33 |
Showing first 500 of 18912 rows.